Clinical Trial Update: A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN) [Phase 3]

View source ↗

Summary

Phase 3 study comparing ETC versus EC-TX regimens and Ibandronate versus observation in node-positive primary breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• EC-TX
• ETC
• Ibandronate (ibandronate)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED